News & Updates

Patients with obesity-related heart failure with preserved ejection fraction (HFpEF) treated with semaglutide are more likely to show an improvement in NYHA functional class at 52 weeks than those who received placebo, according to a study.

Patients who undergo complete revascularization with percutaneous coronary intervention following a myocardial infarction (MI) are at lower risk of all-cause mortality, cardiovascular mortality, MI, major adverse cardiac events (MACE), and repeat revascularization, reports a recent study.

New research has shown that a low-fat vegan diet rich in vegetables, fruits, whole grains, and legumes can improve insulin sensitivity in adult patients with type 1 diabetes (T1D), thus reducing their daily insulin requirements. The finding may fuel the momentum for dietary shifts in this population.

Poor glycaemic control appears to contribute to coronary stent failure driven by in-stent restenosis in patients with type 2 diabetes (T2D), suggests a study.

The direct oral anticoagulants (DOACs) apixaban and rivaroxaban trump warfarin for the treatment of venous thromboembolism (VTE) in a retrospective observational analysis comprising real-world VTE patients from Finland, Norway, and Sweden.

A French study presented at EULAR 2024 reveals an association between statin treatment and an increased risk of total joint replacement in individuals with knee and hip osteoarthritis (OA).